Literature DB >> 26243975

Comprehensive psychological intervention to improve outcome in functional gastrointestinal disorder: a cohort study.

Yu Tien Wang1, Kah Foo Victor Kwok2, Shian Ming Tan2, Ming Hwei Yek2, Wai Choung Ong1, Sylvaine Barbier3, Beng Yeong Ng2.   

Abstract

INTRODUCTION: Patients with functional gastrointestinal disorders (FGIDs) have a decreased quality of life (QoL). Psychological illnesses are strongly associated with FGIDs. This study examined the effect of a comprehensive psychological intervention programme designed for refractory FGID patients.
METHODS: Refractory FGID patients at a tertiary gastroenterology unit were encouraged to participate in a psychological intervention programme, which included screening for anxiety and depression in patients, educating patients and physicians on FGIDs, and providing early access to psychiatric consultation for patients with significant psychological illnesses. The duration of follow-up was six months. Outcomes were measured using the Irritable Bowel Syndrome-QoL (IBS-QoL) instrument and the EuroQol five dimensions (EQ-5D) questionnaire.
RESULTS: A total of 1,189 patients (68% female, 80% Chinese, mean age 48.6 years) participated in the programme. Among these participants, 51% had a significant psychological disorder (Hospital Anxiety and Depression Scale [HADS] anxiety or depression score > 7). These participants had a significantly poorer QoL (IBS-QoL and EQ-5D, both p < 0.0001), and were more likely to be single or English-speaking, as compared to the participants without psychological disorders. Participants who completed ≥ 3 months of follow-up (n = 906) showed significant and durable improvement. High baseline HADS anxiety score predicted improvement (p < 0.001), with participant IBS-QoL and EQ-5D scores decreasing over time.
CONCLUSION: The intervention programme was associated with a clinically meaningful improvement in the QoL of patients with refractory FGIDs. High baseline anxiety was predictive of improvement.

Entities:  

Keywords:  anxiety; irritablae bowel syndrome; psychological intervention

Mesh:

Year:  2015        PMID: 26243975      PMCID: PMC4520917          DOI: 10.11622/smedj.2015109

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  26 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain.

Authors:  L S Walker; J Garber; C A Smith; D A Van Slyke; R L Claar
Journal:  J Consult Clin Psychol       Date:  2001-02

3.  Health-related quality of life among persons with irritable bowel syndrome: a systematic review.

Authors:  H B El-Serag; K Olden; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2002-06       Impact factor: 8.171

4.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

Authors:  D A Drossman; D L Patrick; W E Whitehead; B B Toner; N E Diamant; Y Hu; H Jia; S I Bangdiwala
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

6.  Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.

Authors:  Ron L Akehurst; John E Brazier; Nigel Mathers; Caroline O'Keefe; Eva Kaltenthaler; Anne Morgan; Maria Platts; Stephen J Walters
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Self-management for women with irritable bowel syndrome.

Authors:  Margaret M Heitkemper; Monica E Jarrett; Rona L Levy; Kevin C Cain; Robert L Burr; Andrew Feld; Pam Barney; Pam Weisman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

8.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.

Authors:  Motoyori Kanazawa; Yuka Endo; William E Whitehead; Michiko Kano; Michio Hongo; Shin Fukudo
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

10.  Psychopathology in irritable bowel syndrome: support for a psychophysiological model.

Authors:  Mark A Sykes; Edward B Blanchard; Jeffery Lackner; Laurie Keefer; Susan Krasner
Journal:  J Behav Med       Date:  2003-08
View more
  3 in total

Review 1.  Methods of Evaluation of Anorectal Causes of Obstructed Defecation.

Authors:  Anne C Fabrizio; Yewande Alimi; Anjali S Kumar
Journal:  Clin Colon Rectal Surg       Date:  2017-02

2.  Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial.

Authors:  Xiaofan Chen; Heyun Nie; Wenjun Liu; Xu Zhou; Jianhua Nie; Bin Xie; Dongping Chen; Yiping Jiang; Kunhe Zhang; Ying Fu; Deping Yang; Yan Xiong; Zhangyang Zhao; Xin Sun; Weifeng Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-02       Impact factor: 2.629

3.  Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome.

Authors:  Seung Young Kim; Rok Seon Choung; Seung Ku Lee; Jung Wan Choe; Sung Woo Jung; Jong Jin Hyun; Ja Seol Koo; Sang Woo Lee; Chol Shin
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.